Drug intelligence / Profile preview

Roter Cysticare

Development stage
Unknown
Lead developer
Roter
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Oral
01

Overview

Roter Cysticare is an orally administered medical device developed by Roter for the treatment and prevention of urinary tract infections, specifically cystitis. The product's formulation typically includes a combination of xyloglucan, gelatin (gelose), propolis, and Hibiscus sabdariffa. Its primary mechanism of action is the formation of a protective mechanical barrier in the intestinal lumen, created by the xyloglucan and gelatin components. This physical film prevents the proliferation and subsequent migration of uropathogenic bacteria, such as *Escherichia coli*, from the gastrointestinal tract to the urinary system. By addressing the gut-to-bladder migration pathway, Roter Cysticare provides a non-antibiotic approach to managing recurrent urinary tract support and infection prevention.

Brand names
Roter CysticareCysticare

Beyond the preview

Go deeper on Roter Cysticare.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Roter Cysticare.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call